Inspire Medical Systems (NYSE:INSP) Shares Down 5.4% – What’s Next?

Shares of Inspire Medical Systems, Inc. (NYSE:INSP) fell 5.4% on Tuesday . The company traded as low as $71.62 and last traded at $71.6260. Approximately 577,956 shares were traded during mid-day trading, a decline of 47% from the average session volume of 1,081,862 shares. The stock had previously closed at $75.72.

Analyst Ratings Changes

A number of equities analysts have recently commented on INSP shares. Truist Financial reissued a “hold” rating and set a $62.00 price target (up from $54.00) on shares of Inspire Medical Systems in a report on Tuesday, August 4th. JPMorgan Chase & Co. lifted their target price on Inspire Medical Systems from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Mizuho boosted their target price on Inspire Medical Systems from $55.00 to $65.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 4th. Oppenheimer raised shares of Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 target price for the company in a report on Tuesday, August 4th. Finally, Piper Sandler raised their price target on shares of Inspire Medical Systems from $55.00 to $60.00 and gave the company a “neutral” rating in a research note on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, eleven have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $66.50.

Inspire Medical Systems Stock Down 5.4%

The stock has a 50 day moving average price of $59.97 and a 200 day moving average price of $53.08. The stock has a market capitalization of $2.07 billion, a price-to-earnings ratio of 15.52, a price-to-earnings-growth ratio of 5.84 and a beta of 0.70.

Inspire Medical Systems (NYSE:INSP) last posted its earnings results on Monday, August 3rd. The company reported $0.14 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.38. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The business had revenue of $200.58 million for the quarter, compared to the consensus estimate of $194.72 million. During the same period last year, the company earned $0.45 EPS. The firm’s revenue was down 7.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. Sell-side analysts forecast that Inspire Medical Systems, Inc. will post 1.24 earnings per share for the current fiscal year.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, insider Jason Kelly sold 963 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $59.55, for a total value of $57,346.65. Following the sale, the insider owned 18,985 shares in the company, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Inspire Medical Systems

Large investors have recently modified their holdings of the company. BlackRock Inc. bought a new stake in Inspire Medical Systems in the second quarter valued at $211,341,000. ADAR1 Capital Management LLC grew its holdings in Inspire Medical Systems by 2,601.3% during the first quarter. ADAR1 Capital Management LLC now owns 405,197 shares of the company’s stock worth $20,900,000 after buying an additional 390,197 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Inspire Medical Systems by 66.2% in the second quarter. Assenagon Asset Management S.A. now owns 864,395 shares of the company’s stock valued at $38,561,000 after purchasing an additional 344,221 shares during the last quarter. Nantahala Capital Management LLC bought a new position in shares of Inspire Medical Systems during the 2nd quarter worth approximately $12,021,235. Finally, Bank of America Corp DE purchased a new position in Inspire Medical Systems in the second quarter worth $11,099,000. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc develops and commercializes medical devices for treating moderate to severe obstructive sleep apnea (OSA), a condition in which the upper airway repeatedly becomes blocked during sleep. The company’s primary product is Inspire therapy, an implantable system designed for patients who are unable to use or obtain consistent benefit from continuous positive airway pressure (CPAP) therapy.

The Inspire system uses a small implantable pulse generator, a breathing-sensing lead and a stimulation lead.